FDA Expands Clearance of Ultrasound-Based Software for Percutaneous Soft Tissue Ablation in the Kidney

Previously cleared for liver tumor ablation therapy, the BioTraceIO360 ultrasound software reportedly bolsters pre-procedure planning with ablation zones.

Read the full article on diagnosticimaging.com